Protein kinase C theta (PKCθ): A key player in T cell life and death

Pharmacological Research

Volumn 55, Issue 6, 2007, Pages 537-544

  Hayashi, Keitaro ^a   Altman, Amnon ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

CD28; PKC ; Signal transduction; T cell; TCR

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE C THETA; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT;

APOPTOSIS; BIOCHEMISTRY; CELL DEATH; CELL FUNCTION; CELL MATURATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME REGULATION; ENZYME STRUCTURE; GENE MUTATION; HELPER CELL; HUMAN; IMMUNE SYSTEM; IN VIVO STUDY; INFLAMMATION; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STIMULATION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH2 CELL;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL SURVIVAL; HUMANS; ISOENZYMES; LYMPHOCYTE ACTIVATION; MICE; MUTATION; PROTEIN KINASE C; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 34250692040     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2007.04.009     Document Type: Review

References (85)

1. Baier G., Telford D., Giampa L., et al. Molecular cloning and characterization of PKCθ, a human novel member of the protein kinase C (PKC) gene family expressed predominantly in hematopoietic cells. J Biol Chem 268 (1993) 4997-5004
2. Chang J.D., Xu Y., Raychowdhury M.K., et al. Molecular cloning and expression of a cDNA encoding a novel isoenzyme of protein kinase C (nPKC). A new member of the nPKC family expressed in skeletal muscle, megakaryoblastic cells, and platelets. J Biol Chem 268 (1993) 14208-14214
3. Osada S., Mizuno K., Saido T.C., et al. A new member of the protein kinase C family, nPKCθ, predominantly expressed in skeletal muscle. Mol Cell Biol 12 (1992) 3930-3938
4. Altman A., and Villalba M. Protein kinase C-θ (PKCθ): it's all about location, location, location. Immunol Rev 192 (2003) 53-63
5. Arendt C.W., Albrecht B., Soos T.J., et al. Protein kinase C-θ: signaling from the center of the T-cell synapse. Curr Opin Immunol 14 (2002) 323-330
6. Isakov N., and Altman A. Protein kinase C-θ in T cell activation. Annu Rev Immunol 20 (2002) 761-794
7. Liu Y., Witte S., Liu Y.C., et al. Regulation of protein kinase Cθ function during T cell activation by Lck-mediated tyrosine phosphorylation. J Biol Chem 275 (2000) 3603-3609
8. Spitaler M., and Cantrell D.A. Protein kinase C and beyond. Nat Immunol 5 (2004) 785-790
9. Monks C.R.F., Kupfer H., Tamir I., et al. Selective modulation of protein kinase C-θ during T-cell activation. Nature 385 (1997) 83-86
10. Grakoui A., Bromley S.K., Sumen C., et al. The immunological synapse: a molecular machine controlling T cell activation. Science 285 (1999) 221-227
11. Dustin M.L., and Chan A.C. Signaling takes shape in the immune system. Cell 103 (2000) 283-294
12. Dustin M.L., and Cooper J.A. The immunological synapse and the actin cytoskeleton: molecular hardware for T cell signaling. Nat Immunol 1 (2000) 23-29
13. Penninger J.M., and Crabtree G.R. The actin cytoskeleton and lymphocyte activation. Cell 96 (1999) 9-12
14. Wülfing C., and Davis M.M. A receptor/cytoskeletal movement triggered by costimulation during T cell activation. Science 282 (1998) 2266-2269
15. Bi K., and Altman A. Lipid microdomains and the role of PKCθ in T cell activation. Semin Immunol 13 (2001) 139-146
16. Miceli M.C., Moran M., Chung C.D., et al. Co-stimulation and counter-stimulation: lipid raft clustering controls TCR signaling and functional outcomes. Semin Immunol 13 (2001) 115-128
17. Xavier R., and Seed B. Membrane compartmentation and the response to antigen. Curr Opin Immunol 11 (1999) 265-269
18. Monks C.R., Freiberg B.A., Kupfer H., et al. Three-dimensional segregation of supramolecular clusters in T cells. Nature 395 (1998) 82-86
19. Dustin M.L. A dynamic view of the immunological synapse. Semin Immunol 17 (2005) 400-410
20. Bi K., Tanaka Y., Coudronniere N., et al. Antigen-induced translocation of PKC-θ to membrane rafts is required for T cell activation. Nat Immunol 2 (2001) 556-563
21. Burack W.R., Lee K.H., Holdorf A.D., et al. Cutting edge: quantitative imaging of raft accumulation in the immunological synapse. J Immunol 15 169 (2002) 2837-2841
22. Huang J., Lo P.F., Zal T., et al. CD28 plays a critical role in the segregation of PKCθ within the immunologic synapse. Proc Natl Acad Sci USA 99 (2002) 9369-9373
23. Chambers C.A., and Allison J.P. Costimulatory regulation of T cell function. Curr Opin Cell Biol 11 (1999) 203-210
24. Schwartz R.H. T cell clonal anergy. Curr Opin Immunol 9 (1997) 351-357
25. Sun Z., Arendt C.W., Ellmeier W., et al. PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes. Nature 404 (2000) 402-407
26. McGuire K.L., and Iacobelli M. Involvement of Rel, Fos, and Jun proteins in binding activity to the IL-2 promoter CD28 response element/AP-1 sequence in human T cells. J Immunol 159 (1997) 1319-1327
27. Manicassamy S., Sadim M., Ye R.D., et al. Differential roles of PKC-θ in the regulation of intracellular calcium concentration in primary T cells. J Mol Biol 355 (2006) 347-359
28. 2+ mobilization and NFAT cell activation in primary mouse T cells. J Exp Med 197 (2003) 1525-1535
29. Lin X., and Wang D. The roles of CARMA1, Bcl10, and MALT1 in antigen receptor signaling. Semin Immunol 16 (2004) 429-435
30. Weil R., and Israel A. T-cell-receptor- and B-cell-receptor-mediated activation of NF-κB in lymphocytes. Curr Opin Immunol 16 (2004) 374-381
31. Hara H., Bakal C., Wada T., et al. The molecular adapter Carma1 controls entry of IκB kinase into the central immune synapse. J Exp Med 200 (2004) 1167-1177
32. Jun J.E., Wilson L.E., Vinuesa C.G., et al. Identifying the MAGUK protein Carma-1 as a central regulator of humoral immune responses and atopy by genome-wide mouse mutagenesis. Immunity 18 (2003) 751-762
33. Wang D., You Y., Case S.M., et al. A requirement for CARMA1 in TCR-induced NF-κB activation. Nat Immunol 3 (2002) 830-835
34. Sommer K., Guo B., Pomerantz J.L., et al. Phosphorylation of the CARMA1 linker controls NF-κB activation. Immunity 23 (2005) 561-574
35. Matsumoto R., Wang D., Blonska M., et al. Phosphorylation of CARMA1 plays a critical role in T cell receptor-mediated NF-κB activation. Immunity 23 (2005) 575-585
36. Sun L., Deng L., Ea C.K., et al. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol Cell 14 (2004) 289-301
37. Ghosh S., and Karin M. Missing pieces in the NF-κB puzzle. Cell 109 Suppl (2002) S81-S96
38. Li Y., Sedwick C.E., Hu J., et al. Role for protein kinase C-θ (PKCθ) in TCR/CD28-mediated signaling through the canonical but not the non-canonical pathway for NF-κB activation. J Biol Chem 280 (2005) 1217-1223
39. Baier-Bitterlich G., Überall F., Bauer B., et al. PKCθ isoenzyme selective stimulation of the transcription factor complex AP-1 in T lymphocytes. Mol Cell Biol 16 (1996) 1842-1850
40. Shaulian E., and Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol 4 (2002) E131-E136
41. + T cells. J Immunol 175 (2005) 5126-5134
42. Li Y., Hu J., Vita R., et al. SPAK kinase is a substrate and target of PKCθ in T-cell receptor-induced AP-1 activation pathway. EMBO J 23 (2004) 1112-1122
43. 2+ signaling by PKCθ in restimulated T cells via a Tec kinase-dependent pathway. Eur J Immunol 34 (2004) 2001-2011
44. Spitaler M., Emslie E., Wood C.D., et al. Diacylglycerol and protein kinase D localization during T lymphocyte activation. Immunity 24 (2006) 535-546
45. Schechtman D., and Mochly-Rosen D. Adaptor proteins in protein kinase C-mediated signal transduction. Oncogene 20 (2001) 6339-6347
46. Benes C.H., Wu N., Elia A.E., et al. The C2 domain of PKCδ is a phosphotyrosine binding domain. Cell 121 (2005) 271-280
47. Villalba M., Coudronniere N., Deckert M., et al. A novel functional interaction between Vav and PKCθ is required for TCR-induced T cell activation. Immunity 12 (2000) 151-160
48. Villalba M., Bi K., Hu J., et al. Translocation of PKCθ in T cells is mediated by a nonconventional, PI3-K- and Vav-dependent pathway, but does not absolutely require phospholipase C. J Cell Biol 157 (2002) 253-263
49. Toker A., and Newton A.C. Cellular signaling: pivoting around PDK-1. Cell 103 (2000) 185-188
50. Lee K.Y., D'Acquisto F., Hayden M.S., et al. PDK1 nucleates T cell receptor-induced signaling complex for NF-κB activation. Science 308 (2005) 114-118
51. Gruber T., Freeley M., Thuille N., et al. Comment on "PDK1 nucleates T cell receptor-induced signaling complex for NF-κB activation". Science 312 (2006) 55 [author reply 55]
52. Nishikawa K., Toker A., Johannes F.-J., et al. Determination of the specific substrate sequence motifs of protein kinase C isozymes. J Biol Chem 272 (1997) 952-960
53. Pietromonaco S.F., Simons P.C., Altman A., et al. Protein kinase C-θ phosphorylation of moesin in the actin-binding sequence. J Biol Chem 273 (1998) 7594-7603
54. Allenspach E.J., Cullinan P., Tong J., et al. ERM-dependent movement of CD43 defines a novel protein complex distal to the immunological synapse. Immunity 15 (2001) 739-750
55. Delon J., Kaibuchi K., and Germain R.N. Exclusion of CD43 from the immunological synapse is mediated by phosphorylation-regulated relocation of the cytoskeletal adaptor moesin. Immunity 15 (2001) 691-701
56. Yonemura S., Nagafuchi A., Sato N., et al. Concentration of an integral membrane protein, CD43 (leukosialin, sialophorin), in the cleavage furrow through the interaction of its cytoplasmic domain with actin-based cytoskeletons. J Cell Biol 120 (1993) 437-449
57. Sasahara Y., Rachid R., Byrne M.J., et al. Mechanism of recruitment of WASP to the immunological synapse and of its activation following TCR ligation. Mol Cell 10 (2002) 1269-1281
58. Snapper S.B., Rosen F.S., Mizoguchi E., et al. Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. Immunity 9 (1998) 81-91
59. Li Y., Soos T.J., Li X., et al. Protein kinase C θ inhibits insulin signaling by phosphorylating IRS1 at Ser-1101. J Biol Chem 279 (2004) 45304-45307
60. Kim J.K., Fillmore J.J., Sunshine M.J., et al. PKC-θ knockout mice are protected from fat-induced insulin resistance. J Clin Invest 114 (2004) 823-827
61. Liu Y., Graham C., Li A., et al. Phosphorylation of the protein kinase C-θ activation loop and hydrophobic motif regulates its kinase activity, but only activation loop phosphorylation is critical to in vivo nuclear-factor-κB induction. Biochem J 361 Pt 2 (2002) 255-265
62. Thuille N., Heit I., Fresser F., et al. Critical role of novel Thr-219 autophosphorylation for the cellular function of PKCθ in T lymphocytes. EMBO J 24 (2005) 3869-3880
63. Berg-Brown N.N., Gronski M.A., Jones R.G., et al. PKCθ signals activation versus tolerance in vivo. J Exp Med 199 (2004) 743-752
64. + T cell effector and memory responses. Proc Natl Acad Sci USA 102 (2005) 14374-14379
65. Giannoni F., Lyon A.B., Wareing M.D., et al. Protein kinase C θ is not essential for T-cell-mediated clearance of murine gammaherpesvirus 68. J Virol 79 (2005) 6808-6813
66. Marsland B.J., Soos T.J., Spath G., et al. Protein kinase C θ Is critical for the development of in vivo T helper Th2 cell but not Th1 cell responses. J Exp Med 200 (2004) 181-189
67. Salek-Ardakani S., So T., Halteman B.S., et al. Differential regulation of Th2 and Th1 lung inflammatory responses by PKCθ. J Immunol 173 (2004) 6440-6447
68. Mowen K.A., and Glimcher L.H. Signaling pathways in Th2 development. Immunol Rev 202 (2004) 203-222
69. Stevens L., Htut T.M., White D., et al. Involvement of GATA3 in protein kinase C θ-induced Th2 cytokine expression. Eur J Immunol 36 (2006) 3305-3314
70. Salek-Ardakani S., So T., Halteman B.S., et al. Protein kinase Cθ controls Th1 cells in experimental autoimmune encephalomyelitis. J Immunol 175 (2005) 7635-7641
71. Tan S.L., Zhao J., Bi C., et al. Resistance to experimental autoimmune encephalomyelitis and impaired IL-17 production in protein kinase C θ-deficient mice. J Immunol 176 (2006) 2872-2879
72. Anderson K., Fitzgerald M., Dupont M., et al. Mice deficient in PKC θ demonstrate impaired in vivo T cell activation and protection from T cell-mediated inflammatory diseases. Autoimmunity 39 (2006) 469-478
73. Healy A.M., Izmailova E., Fitzgerald M., et al. PKC-θ-deficient mice are protected from Th1-dependent antigen-induced arthritis. J Immunol 177 (2006) 1886-1893
74. Harrington L.E., Mangan P.R., and Weaver C.T. Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol 18 (2006) 349-356
75. Weaver C.T., Harrington L.E., Mangan P.R., et al. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24 (2006) 677-688
76. Bettelli E., Carrier Y., Gao W., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441 (2006) 235-238
77. Berenson L.S., Ota N., and Murphy K.M. Issues in T-helper 1 development-resolved and unresolved. Immunol Rev 202 (2004) 157-174
78. + regulatory and natural killer-like T cells on signals leading to NF-κB activation. Proc Natl Acad Sci USA 101 (2004) 4566-4571
79. L. Immunity 3 (1995) 87-98
80. Bertolotto C., Maulon L., Filippa N., et al. PKC-θ and ε promote T cell survival by a Rsk-dependent phosphorylation and inactivation of BAD. J Biol Chem 275 (2000) 37246-37250
81. Villalba M., Bushway P., and Altman A. PKCθ mediates a selective T cell survival signal via phosphorylation of BAD. J Immunol 166 (2001) 5955-5963
82. Hindley A., and Kolch W. Raf-1 and B-Raf promote protein kinase C theta interaction with BAD. Cell Signal 19 (2006) 547-555
83. + T cell survival by up-regulating Bcl-xL. J Immunol 176 (2006) 6709-6716
84. Zhou T., Song L., Yang P., et al. Bisindolylmaleimide VIII facilitates Fas-mediated apoptosis and inhibits T cell-mediated autoimmune diseases. Nat Med 5 (1999) 42-48
85. Villalba M., and Altman A. Protein kinase C-theta (PKC-theta), an example of a drug target for therapeutic intervention with human T cell leukemias. Curr Cancer Drug Targets 2 (2002) 125-134